Arecor Therapeutics Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Arecor Therapeutics is a clinical-stage biotechnology company developing therapies for diabetes, obesity and other cardiometabolic diseases, with the goal of reducing treatment burden and improving outcomes. It is based in Little Chesterford, England, in the East of England region, and operates as a small-to-mid-sized enterprise focused on translational research and clinical development. The company sits within the biotechnology research industry, pursuing approaches that seek to enhance existing therapies through novel formulations. Its work is centered on bringing forward therapeutics intended to address unmet needs in metabolic health. In 2025, Arecor announced a formulation development collaboration with Skye Bioscience to produce a higher-concentration formulation of nimacimab, an investigational CB1 inhibitor for obesity. It has also indicated participation in industry events, including an upcoming presentation at the Oppenheimer Annual Healthcare Medtech & Services Conference in March 2026.
1-888-653-2347 
support@leadiq.com 
